PR Newswire
February 12, 2026
BioMarin Announces Closing of Private Offering of Senior Notes
/PRNewswire/ — BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) (“BioMarin”) announced today that it closed its previously announced offering of $850 million of…